Take part in one hemodialysis session to evaluate Qidni Labs’ nearly waterless and portable dialysis system
Overview
Qidni Labs is inviting up to 30 patients with kidney failure to take part in one session of hemodialysis for a research study. This study is evaluating the safety and efficacy of the “Qidni/D” device as a possible treatment for kidney failure. The Qidni/D is a portable hemodialysis device that would significantly lower the requirement for clean water and supporting infrastructure to perform dialysis, making dialysis fully accessible on a global scale.
Through this study, you will:
- Partake in one session of dialysis using the Qidni/D
- Undergo treatment for 30 minutes up to 4 hours
- Have a very similar experience to that of standard dialysis practice
- Use your current vascular access
- Be provided with compensation
Eligibility
Basic eligibility criteria requires participants to be:
- Over 18 years and less than 75 years of age
- Volunteer has kidney failure and has been treated with maintenance dialysis for at least 3 months
Further eligibility criteria and screening will be evaluated on a per participant basis.
Participants will be expected to attend and complete one study treatment for a prescribed duration (up to 4 hours) with the Qidni/D device. Treatment will take place within the Kitchener-Waterloo region in Ontario.
This is a Canada-wide study and the sponsor (Qidni Labs Inc.) will fly participants into the local clinic if needed.
